Guidelines Updated for Diagnosis, Management of NAFLD

This article originally appeared here.
Share this content:
Guidelines Updated for Diagnosis, Management of NAFLD
Guidelines Updated for Diagnosis, Management of NAFLD

TUESDAY, July 18, 2017 (HealthDay News) -- A practice guidance statement, published online July 17 in Hepatology, has been developed to augment the clinical practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease (NAFLD).

Naga Chalasani, M.D., from the Indiana University School of Medicine in Indianapolis, and colleagues published the guidance document as an update to the 2012 practice guideline for the diagnosis and management of NAFLD. The authors note that few studies report the incidence of NAFLD in Asian countries, and rates are less commonly reported in populations of Western countries.

Based on imaging, the overall global prevalence of NAFLD is estimated at 25.24 percent, with the highest prevalence reported from the Middle East and South America. Systematic screening for NAFLD is recommended for higher-risk individuals with diabetes or obesity. Liver biopsy should be performed in patients who would derive most benefit from diagnostic, therapeutic guidance, and prognostic information. Management of NAFLD should include treating liver disease and associated metabolic comorbidities. Pharmacologic treatments aimed at improving liver disease should be limited to those with biopsy-proven nonalcoholic liver steatohepatitis (NASH) and fibrosis. Lifestyle modification including diet, exercise, and weight loss is recommended for patients with NAFLD, with weight loss key to improving histopathologic features of NASH.

"As clinically appropriate, guidance statements should be tailored for individual patients," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Ad Campaign Hopes to Halt E-Cigarette Use Among Teens

FDA Ad Campaign Hopes to Halt E-Cigarette Use ...

'The Real Cost' Youth E-Cigarette Prevention Campaign to target at-risk youth

U.S. Senate Passes Opioids Bill

U.S. Senate Passes Opioids Bill

Comprehensive bipartisan package earmarks billions of dollars to fight opioid abuse in the United States

Active Choice Intervention Tied to Increase in Flu Shot Rates

Active Choice Intervention Tied to Increase in Flu ...

Vaccination rates decrease throughout the day; with intervention, similar increase throughout day

is free, fast, and customized just for you!




Already a member?

Sign In Now »